30-day Federal Register Notice

36112

Federal Register / Vol. 84, No. 144 / Friday, July 26, 2019 / Notices

jbell on DSK3GLQ082PROD with NOTICES

legitimate access to controlled
substances, including opioids, while
also preventing diversion and abuse, as
well as how federal, state, local, and
tribal entities can collaborate to address
these issues.
DATES: Comments must be received at
one of the addresses provided below, no
later than 5 p.m. on August 26, 2019.
ADDRESSES: Written comments can be
provided by email, fax or U.S. mail.
Email: [email protected].
Fax: (202) 690–5882.
Mail: U.S. Department of Health and
Human Services, Office of the Assistant
Secretary for Planning and Evaluation,
Office of Science and Data Policy, Attn:
EPAEDEA Report Feedback, 200
Independence Avenue SW, Room 434E,
Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Jessica White, Office of the Assistant
Secretary for Planning and Evaluation,
202–690–7100.
SUPPLEMENTARY INFORMATION:
I. Background
Section 3 of the Ensuring Patient
Access and Effective Drug Enforcement
Act of 2016 (EPAEDEA), Public Law
114–145, called for the Department of
Health and Human Services, acting
through the Commissioner of Food and
Drugs, the Administrator of the
Substance Abuse and Mental Health
Services Administration, the Director of
the Agency for Healthcare Research and
Quality, and the Director of the Centers
for Disease Control and Prevention, and
in coordination with the Administrator
of the Drug Enforcement Administration
and in consultation with the Secretary
of Defense and the Secretary of Veterans
Affairs, to submit a report to Congress
that identifies:
• Obstacles to legitimate patient access
to controlled substances
• issues with diversion of controlled
substances
• how collaboration between Federal,
State, local, and tribal law
enforcement agencies and the
pharmaceutical industry can benefit
patients and prevent diversion and
abuse of controlled substances;
• the availability of medical education,
training opportunities, and
comprehensive clinical guidance for
pain management and opioid
prescribing, and any gaps that should
be addressed
• beneficial enhancements to State
prescription drug monitoring
programs, including enhancements to
require comprehensive prescriber
input and to expand access to the
programs for appropriate authorized
users

VerDate Sep<11>2014

17:54 Jul 25, 2019

Jkt 247001

• steps to improve reporting
requirements so that the public and
Congress have more information
regarding prescription opioids, such
as the volume and formulation of
prescription opioids prescribed
annually, the dispensing of such
prescription opioids, and outliers and
trends within large data sets.

The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

II. Solicitation of Comments
EPAEDEA requires that the report
incorporate feedback and
recommendations from the following:
(1) Patient groups; (2) pharmacies; (3)
drug manufacturers; (4) common or
contract carriers and warehousemen; (5)
hospitals, physicians, and other health
care providers; (6) State attorneys
general; (7) Federal, State, local, and
tribal law enforcement agencies; (8)
health insurance providers and entities
that provide pharmacy benefit
management services on behalf of a
health insurance provider; (9) wholesale
drug distributors; (10) veterinarians; (11)
professional medical societies and
boards; (12) State and local public
health authorities; and (13) health
services research organizations.
This RFI is seeking comment from
these stakeholders on the
aforementioned issue areas to be
covered by the report.

Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Review for: HEAL:
Optimization of Non-addictive Therapies
[Small Molecules and Biologics] to Treat
Pain.
Date: July 26, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Marilyn Moore-Hoon,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, National Institute of Neurological
Disorders and Stroke, Bethesda, MD 20892,
301–827–9087, [email protected].
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)

III. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble.
Dated: July 16, 2019.
Brenda Destro,
Deputy Assistant Secretary for Planning and
Evaluation (HSP).
[FR Doc. 2019–15952 Filed 7–25–19; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.

Frm 00064

Fmt 4703

[FR Doc. 2019–15879 Filed 7–25–19; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Immigration and Customs
Enforcement
[OMB Control Number 1653–0043]

BILLING CODE 4150–15–P

PO 00000

Dated: July 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.

Sfmt 4703

Agency Information Collection
Activities; Extension of a Currently
Approved Collection: Electronic Funds
Transfer Waiver Request; Comment
Request
U.S. Immigration and Customs
Enforcement, Department of Homeland
Security.
ACTION: 30-Day notice.
AGENCY:

In accordance with the
Paperwork Reductions Act (PRA) of
1995 the Department of Homeland
Security (DHS), U.S. Immigration and
Customs Enforcement (ICE) will submit
the following Information Collection
Request (ICR) to the Office of

SUMMARY:

E:\FR\FM\26JYN1.SGM

26JYN1

jbell on DSK3GLQ082PROD with NOTICES

Federal Register / Vol. 84, No. 144 / Friday, July 26, 2019 / Notices
Management and Budget (OMB) for
review and clearance. This information
collection was previously published in
the Federal Register (84 FR 23577) on
May 22, 2019, allowing for a 60-day
comment period. ICE received one
comment in connection with the 60-day
notice. The purpose of this notice is to
allow an additional 30 days for public
comments.
DATES: Comments are encouraged and
will be accepted until August 26, 2019.
ADDRESSES: Interested persons are
invited to submit written comments
and/or suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, to the
Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to the OMB Desk Officer for U.S.
Immigration and Customs Enforcement,
Department of Homeland Security, and
sent via electronic mail to
[email protected] or faxed to
(202) 395–5806. All submissions must
include the words ‘‘Department of
Homeland Security’’ and the OMB
Control Number 1653–0043.
SUPPLEMENTARY INFORMATION:

(2) Title of the Form/Collection:
Electronic Funds Transfer Waiver
Request.
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: 10–002; U.S.
Immigration and Customs Enforcement.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State, Local, or Tribal
Government. Section 404(b) of the
Immigration and Nationality Act (8
U.S.C. 1101 (note) provides for the
reimbursement to States and localities
for assistance provided in meeting an
immigration emergency. This collection
of information allows for State or local
governments to request reimbursement.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 650 responses at 30 minutes
(.50 hours) per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: 325 annual burden hours.
(7) An estimate of the total public
burden (in cost) associated with the
collection: The estimated annual cost
burden associated with this collection of
information is $10,468.

Comments

Dated: July 23, 2019.
Scott Elmore,
PRA Clearance Officer.

Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a Currently Approved
Collection.

VerDate Sep<11>2014

17:54 Jul 25, 2019

Jkt 247001

[FR Doc. 2019–15887 Filed 7–25–19; 8:45 am]
BILLING CODE 9111–28–P

DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R2–ES–2018–N161;
FXES11130200000–190–FF02ENEH00]

Endangered and Threatened Wildlife
and Plants; Initiation of 5-Year Status
Reviews of 36 Species in Arizona, New
Mexico, Texas, Utah, and Mexico
Fish and Wildlife Service,
Interior.
ACTION: Notice of initiation of reviews;
request for information.
AGENCY:

We, the U.S. Fish and
Wildlife Service, are conducting 5-year
status reviews under the Endangered
Species Act of 36 animal and plant
species. A 5-year status review is based
on the best scientific and commercial
data available at the time of the review;
therefore, we are requesting submission
of any such information that has become
available since the last review for the
species.

SUMMARY:

To ensure consideration, we are
requesting submission of new

DATES:

PO 00000

Frm 00065

Fmt 4703

Sfmt 4703

36113

information no later than August 26,
2019. However, we will continue to
accept new information about any listed
species at any time.
ADDRESSES: For how to submit
information, see Request for Information
and How Do I Ask Questions or Provide
Information? in the SUPPLEMENTARY
INFORMATION section.
FOR FURTHER INFORMATION CONTACT: For
information on a particular species,
contact the appropriate person or office
listed in the table in the SUPPLEMENTARY
INFORMATION section. Individuals who
are hearing impaired or speech impaired
may call the Federal Relay Service at
800–877–8339 for TTY assistance.
SUPPLEMENTARY INFORMATION:
Why do we conduct a 5-year review?
Under the Endangered Species Act of
1973, as amended (ESA; 16 U.S.C. 1531
et seq.), we maintain Lists of
Endangered and Threatened Wildlife
and Plants (which we collectively refer
to as the List). Wildlife and plants on
the List can be found at http://
ecos.fws.gov/tess_public/pub/listed
Animals.jsp and http://ecos.fws.gov/
tess_public/pub/listedPlants.jsp,
respectively. Section 4(c)(2)(A) of the
ESA requires us to review each listed
species’ status at least once every 5
years. Our regulations at 50 CFR 424.21
require that we publish a notice in the
Federal Register announcing those
species under active review. For
additional information about 5-year
reviews, refer to our factsheet at http://
www.fws.gov/endangered/what-we-do/
recovery-overview.html.
What information do we consider in
our review?
A 5-year review considers all new
information available at the time of the
review. In conducting these reviews, we
consider the best scientific and
commercial data that have become
available since the listing determination
or most recent status review, such as:
(A) Species biology, including but not
limited to population trends,
distribution, abundance, demographics,
and genetics;
(B) Habitat conditions, including but
not limited to amount, distribution, and
suitability;
(C) Conservation measures that have
been implemented that benefit the
species;
(D) Threat status and trends in
relation to the five listing factors (as
defined in section 4(a)(1) of the ESA);
and
(E) Other new information, data, or
corrections, including but not limited to
taxonomic or nomenclatural changes,

E:\FR\FM\26JYN1.SGM

26JYN1